Tafenoquine lactation pharmacokinetics: a pilot study
Issued Date
2026-12-01
Resource Type
eISSN
14752875
Scopus ID
2-s2.0-105027020172
Pubmed ID
41345660
Journal Title
Malaria Journal
Volume
25
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal Vol.25 No.1 (2026)
Suggested Citation
Gilder M.E., Wattanakul T., Tarning J., Hanpithakpong W., Niwetphongprai L., Chu C.S., Gornsawun G., Tawantochai W., Heet E., Jittamala P., Saito M., White N.J., Nosten F., Bancone G., McGready R. Tafenoquine lactation pharmacokinetics: a pilot study. Malaria Journal Vol.25 No.1 (2026). doi:10.1186/s12936-025-05685-z Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/114757
Title
Tafenoquine lactation pharmacokinetics: a pilot study
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: Radical cure with an 8-aminoquinoline is required to prevent relapses from Plasmodium vivax. Single-dose treatment with tafenoquine offers significant advantages over primaquine, but the amount of tafenoquine excreted in breastmilk is unknown. As tafenoquine can cause serious haemolysis in G6PD deficient individuals, the amount of drug in breastmilk must be determined in order to advise on safe and effective treatment for lactating women. Methods: Six healthy lactating volunteers ≥ 1 year postpartum were recruited for this mother-only pilot pharmacokinetic study. Paired breastmilk and venous samples were taken on day 0, 1, 7 and 14. Breastmilk samples were collected in serial 5 ml aliquots to test foremilk and hindmilk drug concentrations. Results: Tafenoquine concentrations in milk were similar to concentrations in blood (milk/plasma ratio 1.09, range: 0.58–1.63). Concentrations were higher in hindmilk and in lower volume samples. Estimated drug passed to infants was calculated using a standard estimate of milk intake (150 ml per kg per day) and a high intake scenario (200 ml per kg per day). The maximum estimated dose that would be passed to the infant on a single day was 0.050 mg/kg in the first 24 h (range 0.032–0.062 mg/kg). Median weight-adjusted proportion of a therapeutic dose that infants would ingest (relative infant dose, RID) in total ranged from 5.07% (assuming of 150 ml milk per kg per day and 10 mg/kg therapeutic dose) to 13.52% (assuming 200 ml milk per kg per day and 5 mg/kg therapeutic dose). The drug was well tolerated by mothers. Discussion: This pilot study demonstrated measurable tafenoquine in breastmilk, with very small amounts of drug passing to babies on any given day but overall estimated RIDs around the conventional 10% threshold for safety concerns. Further studies are needed to determine with greater certainty the excretion of tafenoquine in breastmilk and drug concentrations in infant blood to inform recommendations for breastfeeding women.